|
ZNF280C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.321900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.678400E-01 |
| Normal-vs-Stage2 |
1.398630E-01 |
| Normal-vs-Stage3 |
6.260000E-03 |
| Normal-vs-Stage4 |
6.358200E-02 |
| Stage1-vs-Stage2 |
1.734240E-01 |
| Stage1-vs-Stage3 |
1.961010E-03 |
| Stage1-vs-Stage4 |
1.062150E-02 |
| Stage2-vs-Stage3 |
8.114200E-01 |
| Stage2-vs-Stage4 |
9.878200E-01 |
| Stage3-vs-Stage4 |
7.314000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.744200E-02 |
| Normal-vs-AfricanAmerican |
2.320000E-01 |
| Normal-vs-Asian |
2.040600E-01 |
| Caucasian-vs-AfricanAmerican |
8.928000E-01 |
| Caucasian-vs-Asian |
2.966200E-01 |
| AfricanAmerican-vs-Asian |
5.203400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.404000E-01 |
| Normal-vs-Female |
2.214500E-04 |
| Male-vs-Female |
3.212600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.260840E-01 |
| Normal-vs-Extreme_Weight |
9.058200E-01 |
| Normal-vs-Obese |
3.539600E-02 |
| Normal-vs-Extreme_Obese |
8.381800E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.364360E-01 |
| Normal_Weight-vs-Obese |
3.797000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.379400E-01 |
| Extreme_Weight-vs-Obese |
4.244500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.393400E-01 |
| Obese-vs-Extreme_Obese |
8.210100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.089810E-02 |
| Normal-vs-Age(41-60Yrs) |
6.678700E-03 |
| Normal-vs-Age(61-80Yrs) |
4.555200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.318600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.678500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.144470E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.381400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.926200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.632400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.567400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.293600E-01 |
| Normal-VS-Type2 PRCC |
1.686950E-01 |
| Normal-VS-KIRP CIMP |
1.321980E-02 |
| Normal-VS-Unclassified PRCC |
3.642000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.595600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.883920E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.754180E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.603500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.834400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.466500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.918200E-01 |
| Normal-vs-N1 |
7.605400E-04 |
| Normal-vs-N2 |
4.732000E-02 |
| N0-vs-N1 |
1.702410E-03 |
| N0-vs-N2 |
2.170000E-01 |
| N1-vs-N2 |
3.965000E-01 |
|
|
